Literature DB >> 20070934

Large measles epidemic in Switzerland from 2006 to 2009: consequences for the elimination of measles in Europe.

J L Richard1, V Masserey Spicher.   

Abstract

Switzerland adheres to the objective of eliminating measles within the European region of the World Health Organization (WHO) by 2010. After several years with a relatively low annual incidence rate (0.3 to 1 case per 100,000 inhabitants), there has been a large epidemic of measles from November 2006 to August 2009. By mid September 2009, 4,415 cases were notified by physicians and laboratories, corresponding to an incidence rate of 15 per 100,000 in 2007 and 29 per 100,000 in 2008; by far the highest rates in Europe. This exceptionally long nationwide epidemic comprised three successive waves, with peaks in August 2007 (171 cases), March 2008 (569 cases) and March 2009 (417 cases). It mainly affected children aged from five to 14 years (48% of cases). Most cases were not vaccinated (93%) or were incompletely vaccinated (5%). In total 656 patients (15%) suffered complications or were hospitalised. Insufficient, spatially heterogeneous immunisation coverage (87% for at least one dose at the age of two years at the national level) has allowed a sequence of numerous outbreaks to occur, despite the gradual strengthening of measures to control the disease. Several exportations to Europe (81 in 2007 and 2008) and to the rest of the world (10 for the whole of the epidemic) have in some instances caused large outbreaks. The epidemic was a threat to the goal of eliminating measles in Switzerland and in Europe. The Federal Office of Public Health (FOPH) and its partners are currently working on a national strategy to eliminate measles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20070934

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  20 in total

1.  Similarity of parents and physicians in the decision to vaccinate children against measles, mumps and rubella.

Authors:  P Kriwy
Journal:  Int J Public Health       Date:  2011-12-16       Impact factor: 3.380

Review 2.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

3.  The Swiss National Vaccination Coverage Survey, 2005-2007.

Authors:  Phung Lang; Hanspeter Zimmermann; Ursula Piller; Robert Steffen; Christoph Hatz
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

Review 4.  Measles Vaccine.

Authors:  Diane E Griffin
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

Review 5.  Measles virus-induced suppression of immune responses.

Authors:  Diane E Griffin
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

6.  Rethinking herd immunity.

Authors:  Lynne Peeples
Journal:  Nat Med       Date:  2019-08       Impact factor: 53.440

7.  Application of the Parent Attitudes about Childhood Vaccines (PACV) survey in three national languages in Switzerland: Exploratory factor analysis and Mokken scale analysis.

Authors:  Victoria O Olarewaju; Kristen Jafflin; Michael J Deml; Clara Zimmermann; Joanna Sonderegger; Thierry Preda; Hanna Staub; Marek Kwiatkowski; Andrea Kloetzer; Benedikt M Huber; Sonja Merten; Philip E Tarr
Journal:  Hum Vaccin Immunother       Date:  2021-03-24       Impact factor: 3.452

8.  'I know it has worked for millions of years': the role of the 'natural' in parental reasoning against child immunization in a qualitative study in Switzerland.

Authors:  Karin Gross; Karin Hartmann; Elisabeth Zemp; Sonja Merten
Journal:  BMC Public Health       Date:  2015-04-12       Impact factor: 3.295

9.  Measles Vaccination Coverage and Cases among Vaccinated Persons.

Authors:  Christian L Althaus; Marcel Salathé
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

10.  Addressing issues of vaccination literacy and psychological empowerment in the measles-mumps-rubella (MMR) vaccination decision-making: a qualitative study.

Authors:  Marta Fadda; Miriam K Depping; Peter J Schulz
Journal:  BMC Public Health       Date:  2015-09-02       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.